Clinical Trials on 事件控制 in China
总计2682个结果
-
CCRF Consulting Co., Ltd.Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.未知
-
Shanghai 10th People's Hospital未知血压 | 心血管危险因素 | 总体死亡率 | 心血管死亡率 | 心血管事件 | 靶器官损伤中国
-
Tianjin Chest Hospital未知经皮冠状动脉介入治疗 | 隐静脉移植物疾病 | 主要不良心血管事件 | Virtual Histology Intravascular Ultrasound中国
-
First Affiliated Hospital of Chongqing Medical...完全的
-
Zhong WangShanxi Zhendong Pharmacy Co., Ltd招聘中
-
China National Center for Cardiovascular DiseasesChina International Medical Foundation招聘中
-
Zhong WangShanxi Zhendong pharmaceutical Co. LTD.完全的
-
Chinese Medical Association未知
-
Air Force Military Medical University, China未知To Assess the Long-term Risk for Adverse Events After PE.中国
-
The Second Affiliated Hospital of Chongqing Medical...招聘中
-
Guangzhou University of Traditional Chinese Medicine未知
-
Ruijin Hospital完全的
-
RenJi HospitalBeiGene; Huidu Shanghai Medical Sciences Ltd招聘中泌尿系肿瘤 | 泌尿生殖系统肿瘤 | 膀胱疾病 | 膀胱肿瘤 | 抗肿瘤药 | Tislelizumab 抗肿瘤药,免疫学中国
-
Chinese PLA General HospitalPeking University First Hospital; Xiangya Hospital of Central South University; Peking University... 和其他合作者招聘中
-
First Affiliated Hospital of Wenzhou Medical UniversityQilu Hospital of Shandong University; Eastern Hepatobiliary Surgery Hospital; The First Affiliated...邀请报名
-
Shanghai MicroPort Medical (Group) Co., Ltd.主动,不招人
-
Shanghai Juncell Therapeutics招聘中
-
Nanjing First Hospital, Nanjing Medical UniversityNational Natural Science Foundation of China; Nanjing Medical University招聘中
-
Chinese University of Hong KongLinyi People's Hospital招聘中
-
Shandong Linglong Yingcheng Hospital招聘中
-
Nanfang Hospital, Southern Medical University招聘中
-
Beijing Neurosurgical Institute完全的
-
Second Affiliated Hospital, School of Medicine,...尚未招聘
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Lei Li招聘中宫颈癌 | 免疫疗法 | 生存结果 | 不良事件 | 局部晚期宫颈癌 | 放化疗 | 免疫检查点抑制剂 | 抗程序性细胞死亡受体 1 | Early Stage Cervical Cancer中国
-
Beijing Tiantan Hospital招聘中